JEFFREY STEED: Open Payments
NPI 1932730884 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 4 payments from 4 companies in 2025. Trend: 2023 $6,953 · 2024 $2,439 · 2025 $191
Food & beverage: $108Long term medical supply or device loan: $83
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $83 |
| Boston Scientific Corporation | 1 | $60 |
| ABBVIE INC. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: KISQALI, General - Embolics, EPKINLY, OJJAARA.
Industry payments across CA — which companies pay providers there.
